Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Contemporary Management of HIV: Heavily Treatment–Experienced Patients

Listen to expert insights from Roger Bedimo, MD, MS, FACP, and Eric S. Daar, MD, on optimal management of heavily treatment–experienced patients with HIV, including assessment of virologic failure and current treatment options for patients with multiclass drug resistance.
Roger Bedimo, MD, MS, FACP
Eric S. Daar, MD
Released: December 17, 2020

In this episode, Roger Bedimo, MD, MS, FACP, and Eric S. Daar, MD, discuss caring for heavily treatment–experienced patients with HIV, including assessment of virologic failure and current treatment options for patients with multiclass drug resistance.

Presenters:

Roger Bedimo, MD, MS, FACP
Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Eric S. Daar, MD
Chief
Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
ViiV Healthcare

Related Content

Drs Roger Bedimo, Princy Kumar, and Brian Wood discuss how they manage care of heavily treatment-experienced patient with HIV from Clinical Care Options (CCO)

Roger Bedimo, MD, MS, FACP Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: June 15, 2021

Slides from CCO: Switching ART in HIV: 3-drug therapy, oral 2-drug options, long-acting injectable 2-drug regimens, single tablet regimens (STRs)

Daniel R. Kuritzkes, MD Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: June 7, 2021

Slides from Daniel Kuritzkes and CCO. Switching to long-acting cabotegravir: ATLAS and FLAIR data, starting, dosing regimens, avoiding treatment failure

Daniel R. Kuritzkes, MD Released: June 4, 2021

Drs Roger Bedimo, Princy N. Kumar, and Brian Wood, answer commonly asked questions on managing heavily treatment-experienced patients with HIV

Roger Bedimo, MD, MS, FACP Princy N. Kumar, MD, FIDSA, MACP Brian Wood, MD Released: June 2, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue